Avandia Congestive Heart Failure: Quick Facts
Quick Facts About Avandia & Congestive Heart Failure
- Congestive heart failure occurs when the heart can no longer pump enough blood to maintain adequate circulation. Because the heart doesn’t pump properly, fluids often build up in the lungs.
- More than 65% of deaths among diabetic patients are heart disease related.
- Avandia has been shown in studies to increase the risk of heart attack by 43% and risk cardiovascular death by 64%.
- Avandia was approved for treatment of type 2 diabetes in 1999, a serious and life threatening disease that affects 18 to 20 million Americans.
- The medical term for heart attack is myocardial infarction. A heart attack is also sometimes referred to as a coronary thrombosis or coronary occlusion.
- On June 7, 2007 the FDA issued a black box warning for Avandia. The “black box” warning is the strongest warning that the FDA adds to labels on medications that may pose a health risk to others.